Clinical trial
Evaluation of the Minimally Invasive VenTouch™ System in the Treatment of Functional Mitral Valve Regurgitation (FMR): First-In-Man Continuation Study
NCT02671799 is registered in ClinicalTrials.gov with Mardil Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Minimally Invasive VenTouch™ System in the Treatment of Functional Mitral Valve Regurgitation (FMR): First-In-Man Continuation Study
- Lead sponsor
- Mardil Medical
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- December 31, 2020
- Enrollment
- 15 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
functional mitral regurgitation